The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1
This is a contract result notice, not an open opportunity. Details from the official award data.
Transition and 33 % products:CESW 15 April 2021 to 30 September 2021 (5.5 months);LSNE 15 April 2021 to 28 February 2022 (10.5 months);NWLN 15 April 2021 to 30 June 2022 (14.5 months);100 % Products (All Regions): 15 April 2021 to 28 February 2022 (10.5 months).The total maximum duration of the framework agreement to be no more than 29 months (14.5 months plus options to extend (at the Authority's sole discretion) for up to a further 14.5 months).
Make the case to bid
Reveal who to approach at The NHS Commissioning Board (operating under the name of NHS England), and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-02aba8
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 009271-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
The NHS Commissioning Board (operating under the name of NHS England)’s tender network
Assembling the network…
Similar open tenders
NP39726 Generic and Biosimilar Cancer Medicines
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Lab Consumables – Lot 1 Chromatography & ICP, Lot 2 Chemicals, Lot 3 Reagents
United Utilities Water Limited